Anticancer Dasatinib Monohydrate Powder Pharmaceutical Grade Dasatinib Monohydrate Purity Dasatinib Monohydrate

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Model NO.: D-Sung Dasatinib Monohydrate
• Product Name: Dasatinib Monohydrate
• Name: Dasatinib Monohydrate Powder
• Appearance: Yellow Powder
• Color: Yellow
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anthelmintics
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 863127-77-9
• Mf: C22h28cln7o3s
• Density: 1.408
• MW: 488.00600
• Melting Point: 275-286
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Xi′an Shaanxi
• Production Capacity: 500kg/Month

Product Description

Anticancer Dasatinib Monohydrate Powder Pharmaceutical Grade Dasatinib Monohydrate Purity Dasatinib Monohydrate 

Product Description

Product Details

Product Name	Dasatinib Monohydrate
Appearance	Yellow Powder
CAS No.	863127-77-9
MF	C22H28ClN7O3S

Dasatinib, also known as DASA tin IB, is a gray-white to yellow solid chemical. Dasatinib is an anti-tumor drug. The main clinical treatment is the chronic phase, accelerated phase and blast phase of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) that is resistant to or intolerant to imatinib mesylate. (Acute granular change and acute leaching change) Adult patients.
 

Application&Function

Dasatinib is used in all the stages of chronic myelogenous leukemia that have been treated, including imatinib mesylate/Gleevec (Imatinibmesylate/Gleevec) resistant or intolerable (chronic phase, accelerated phase, lymphoid cell blast phase and myeloid leukemia). Cell blast stage) adult patients. At the same time, the FDA has also approved dasatinib to treat Philadelphia chromosome-positive adult patients with acute lymphoblastic leukemia who are resistant or intolerant to other therapies through normal procedures.

Specification